N. Iravani et al. / Chinese Chemical Letters 22 (2011) 1151–1154
1153
Table 2
Synthesis of 2-aryl-1-arylmethyl-1H-1,3-benzimidazoles catalyzed by SASPSPE at 80 8C in water.
a
b
Entry
Aldehyde
CHO
Product
Time (min)
Yield (%)
87
M
p
(8C)
1
2
3
4
5
6
7
8
9
C
6
H
5
3a
3b
3c
3d
3e
3f
25
130–132
128–130
129–131
150–151
135–137
161–163
82–84
190–192
92–94
–
c
c
4-CH
4-CH
2-CH
3
3
3
C
6
H
4
CHO
25, 25, 30, 35, 35
90, 88, 89, 86, 85
OC
OC
6
H
H
4
CHO
CHO
20
25
30
35
35
35
30
45
45
45
93
6
4
91
4-ClC
2-ClC
6
H
H
4
4
CHO
CHO
90
6
89
4-FC
4-NCC
2-Furyl-CHO
6
H
4
CHO
3g
3h
3i
85
6
H
4
CHO
93
75
10
11
12
CH
CH
3
(CH
(CH
2
)
)
2
–CHO
–CHO
3j
Trace
Trace
–
3
2
6
3k
3l
–
Cyclohexanone
–
a
b
c
The molar ratios of 1,2-phenylenediamine:aldehyde:SASPSPE were used as followed 1:2: and 0.05 (g) respectively at 80 8C in water (5 mL).
Isolated yield.
The recycled catalyst was used.
The recycled catalyst could be reused four times without any treatment. No observation of appreciable loss in its
catalytic activities was shown (Table 2, entry 2).
In conclusion, heterogeneous conditions, green solvent, easy and clean work-up, high yields and recovery of the
catalyst makes this method practical for the synthesis of benzimidazole derivatives.
General procedure, synthesis of 2-aryl-1-arylmethyl-1H-1,3-benzimidazoles
In a round bottomed flask to a mixture of o-phenylenediamine (1 mmol), aromatic aldehyde (2 mmol) in water
5 mL), SASPSPE (0.05 g, 1.7 mol%) were added and the reaction mixture stirred in an oil bath at 80 8C for the
(
appropriate time (see Table 2). The progress of the reaction was followed by TLC. After completion of the reaction, the
mixture was filtered and the precipitates were solved in hot ethanol (3Â 10 mL) and filtered to afford the desired
product. Finally the crude product was recrystallized from water–ethanol (1:1). The recovered catalyst was dried and
reused for subsequent runs.
1
Compound 3a: mp 130–132 8C, Lit. [11] 129–130 8C. H NMR (400 MHz, CDCl ): d 5.37 (s, 2H), 7.02 (dd, 2H,
3
J = 8.1 Hz, J = 1.5 Hz), 7.11–7.17 (m, 2H), 7.21–7.27 (m, 4H), 7.33–7.39 (m, 3H), 7.59–7.62 (m, 2H), 7.79 (dd, 1H,
1
2
1
J = 8.7 Hz, J = 1.0 Hz). C NMR (100 MHz, CDCl ): d 48.42, 110.59, 120.02, 122.73, 123.09, 126.01, 127.82,
3
1
2
3
1
28.80, 129.11, 129.30, 129.97, 130.09, 136.09, 136.42, 143.20, 154.22.
1
Compound 3b: mp 128–130 8C, Lit. [19] 128–130 8C. H NMR (500 MHz, CDCl ): d 2.33 (s, 3H), 2.40 (s, 3H),
3
5
J = 7.8 Hz), 7.86 (d, 1H, J = 8.0 Hz). C NMR (125 MHz, CDCl ): d 21.50, 21.85, 48.65, 110.96, 120.18, 123.06,
.41 (s, 2H), 6.99 (d, 2H, J = 7.8 Hz), 7.13 (d, 2H, J = 7.8 Hz), 7.19–7.26 (m, 4H), 7.30 (t, 1H, J = 7.3 Hz), 7.59 (d, 2H,
1
3
3
1
23.33, 126.32, 127.44, 129.61, 129.88, 130.13, 133.81, 136.45, 137.90, 140.55, 154.68.
1
Compound 3c: mp 129–131 8C, Lit. [19] 129–130 8C. H NMR (500 MHz, CDCl ): d 3.81 (s, 3H), 3.88 (s, 3H),
3
5
.41 (s, 2H), 6.89 (dt, 2H, J = 6.9 Hz, J = 2.4 Hz), 7.01 (dt, 2H, J = 8.8 Hz, J = 2.4 Hz), 7.06 (d, 2H, J = 8.7 Hz),
1
2
1
2
1
.24–7.26 (m, 2H), 7.31–7.34 (m, 1H), 7.68 (dt, 2H, J = 8.8 Hz, J = 2.4 Hz), 7.88 (d, 1H, J = 8.0 Hz). C NMR
3
7
1
2
(
125 MHz, CDCl ): d 48.33, 55.71, 55.80, 110.85, 114.63, 114.86, 120.09, 122.75, 123.00, 123.20, 127.64, 128.86,
3
1
31.15, 136.46, 154.47, 159.56, 161.37.
1
Compound 3d: mp 150–151 8C, Lit. [19] 149–152 8C. H NMR (500 MHz, CDCl ): d 3.59 (s, 3H), 3.77 (s, 3H),
3
5
.24 (s, 2H), 6.70 (d, 1H, J = 6.8 Hz), 6.76 (t, 1H, J = 7.4 Hz), 6.83 (d, 1H, J = 8.2 Hz), 6.96 (d, 1H, J = 8.3 Hz), 7.05
(
t, 1H, J = 7.5 Hz), 7.17–7.28 (m, 4H), 7.45 (dt, 1H, J = 7.9 Hz, J = 1.6 Hz), 7.54 (dd, 1H, J = 7.5 Hz, J = 1.6 Hz),
1 2 1 2
1
.86 (d, 1H, J = 8.0 Hz). C NMR (125 MHz, CDCl ): d 44.07, 55.59, 55.63, 110.40, 111.25, 111.31, 120.07, 120.83,
3
7
1
3
21.25, 122.56, 123.03, 124.83, 127.26, 128.23, 128.89, 131.98, 132.82, 156.96, 158.04.
Acknowledgment
We are thankful to the Islamic Azad University Research Council for the partial support of this work.